Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany
Sponsor: Novartis Pharmaceuticals
Summary
This is a multicenter, non-randomized, non-interventional two-cohort study with prospective collection of primary data on monitoring of Chronic spontaneous urticaria (CSU) patients by telemedicine or F2F visits in routine clinical care. This implementation science study will collect data from patients during routine CSU monitoring via F2F visits or teledermatological visits. The study will be representative for the real-world patient CSU population in Germany.
Official title: A Non-Interventional Study to Compare Digital Monitoring of Patients With Chronic Spontaneous Urticaria by Telemedicine to Face-to-Face Visits in Germany (DigiMoc)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
116
Start Date
2024-06-11
Completion Date
2025-12-31
Last Updated
2025-07-16
Healthy Volunteers
No
Conditions
Interventions
Collection of patient data
This non-interventional study and will not influence treatment decisions
Locations (20)
Novartis Investigative Site
Hamburg, Hamburg, Germany
Novartis Investigative Site
Lingen Ems, Lower Saxony, Germany
Novartis Investigative Site
Koblenz, Rhineland-Palatinate, Germany
Novartis Investigative Site
Leipzig, Saxony, Germany
Novartis Investigative Site
Halle, Saxony-Anhalt, Germany
Novartis Investigative Site
Ahaus, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Bremen, Germany
Novartis Investigative Site
Dortmund, Germany
Novartis Investigative Site
Dresden, Germany
Novartis Investigative Site
Freising, Germany
Novartis Investigative Site
Gelsenkirchen, Germany
Novartis Investigative Site
Gera, Germany
Novartis Investigative Site
Kamen, Germany
Novartis Investigative Site
Mainz, Germany
Novartis Investigative Site
München, Germany
Novartis Investigative Site
Nuremberg, Germany
Novartis Investigative Site
Remscheid, Germany
Novartis Investigative Site
Selters, Germany